Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga September 29, 2015 at 08:22 AM EDT Esperion Therapeutics Inc (NASDAQ: ESPR) shares fell 13.94 percent to $30.20 in pre-market trading following an update on ETC-1002 ... Read More >> Related Stocks: Esperion Theraptc Galapagos NV ADR Jetblue Airways Corp Shire Plc Ads